Making AIDS treatment affordable for all sufferers

Sanders, Bernie
December 2011
Hill;12/1/2011, Vol. 18 Issue 165, p14
In this article, the author discusses the affordable treatment for AIDS/HIV.


Related Articles

  • Crixivan reduces viral load.  // AIDS Patient Care & STDs;Feb1996, Vol. 10 Issue 1, p50 

    Looks at the results of a study on the effects of protease inhibitor crixivan on AIDS patients with viral load. Findings; Reason for study of the drug; Who study was done by.

  • More Drug Reports. Helquist, Michael // Advocate;3/18/86, Issue 442, p25 

    Reports that researchers at the AIDS branch of the U.S. Centers for Disease Control continue to conduct tests of potentially therapeutic agents to be used against AIDS. Ability of rifabutin to block the in vitro infectivity and replication of the AIDS virus; Ability of rifabutin to penetrate...

  • Aids Drug Available In United Kingdom. Helquist, Michael // Advocate;1/19/88, Issue 490, p9 

    Reports on the availability in Great Britain AL-721, a drug for treating AIDS. Physicians' basis for prescribing the drug; Status in the United States; Start of the U.S. National Institutes of Health's study of its effectiveness against persistent generalized lymphadenopathy.

  • ADAP payments OK'd. Bajko, Matthew S. // Bay Area Reporter;8/29/2002, Vol. 32 Issue 35, p12 

    Reports on the California AIDS Drug Assistance Program. Medications paid for by the government; Benefits from the program.

  • Hyperthermia trial expands.  // AIDS Patient Care & STDs;Jun96, Vol. 10 Issue 3, p191 

    Details the US Food and Drug Administration's approval on the expansion of studies of whole-body extracorporeal hyperthermia utilizing the BioLogic-HT System for treatment of HIV/AIDS. Artificial induction of fever; Heat sensitivity of HIV.

  • In the news.  // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p207 

    Presents updates on prevention and treatment of AIDS and HIV as of August 1996. Approval of the US Food and Drug Administration (FDA) to market Amplicor HIV-1 monitor test; New role for CC-CKR5; Viral load to predict HIV disease progression; Link between the treatment of other STDs and...

  • Drug news and trial developments.  // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p231 

    Presents information on drugs and trial developments in the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). AIDS vaccine study by VaxGen Incorporated; Study of HIV-positive patients receiving thalidomide treatment; Approval of rituximab for...

  • Ensuring access to AIDS drugs. Gray, Robin; Habiyambere, Vincent; Renaud-Thery, Francoise // World Health;Nov/Dec98, Vol. 51 Issue 6, p18 

    Deals with the challenge of ensuring access to drugs that would treat AIDS. Different groups of drugs for HIV/AIDS; Goal of equitable access; Objectives; Requirements; Responsibility of governments; Information on the national essential drugs list; Systems responsible for the procurement,...

  • HIV directory.  // New Scientist;02/22/97, Vol. 153 Issue 2070, p43 

    Reviews the book entitled `HIV and AIDS Treatment Directory,' edited by Edward King.

  • Balancing Haves & Have-Nots. Wechsler, Jill // Pharmaceutical Executive;Apr2001, Vol. 21 Issue 4, p26 

    Discusses the challenges faced by pharmaceutical firms in the battle over access to HIV/AIDS therapies in line with the imbalance between poor and rich countries in providing AIDS therapies. Impact of the battle over access to AIDS drugs on the pharmaceutical industry's intellectual property...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics